Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Discover the best cryptocurrencies for beginners. Start your investment journey with these user-friendly options.
5,349 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A surprisingly strong first quarter has some investors asking if Stellantis can shake off years of underperformance. ...
As yields climb, fixed income returns look more attractive for defined time horizons. Investors weigh when bonds perc...
Investing often favors flashy stories, but some of the strongest returns come from straightforward, reliable business...
A fresh look at Fossil's Q1 2026 earnings expectations. Learn what to watch in the report, how margins may trend, and...
Rocket Lab is expanding by purchasing a competing space systems group for up to $60 million. This article breaks down...
Choosing between REET and GQRE comes down to how you want exposure to global real estate. This guide breaks down meth...
Ford surprised markets with an upward revision to its 2026 guidance after a solid first quarter. This article breaks ...
XRP on-chain activity climbs to a fresh milestone as big holders stock up, even as the price slips under $1.45. The m...
Explore Innoviz's path in 2026 with a deep dive into Q1 results, margins, backlog, and strategic bets. This analysis ...
Semiconductors have sprinted this year, but a cooling period is drawing attention. History suggests pauses can lead t...
Regulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...